Sectors
FBRX
Forte Biosciences, Inc.
76.99
42 x 76.99
2 x 98.52
bid
ask
+
0.00
0.00%
22 @ 04:00 PM
77.00 +0.01 (0.01%)
| Ytd | 182.32% | |
| 1y | 583.75% |
76.96
day range
77.00
10.11
52 week range
77.20
| Open | 76.97 | Prev Close | 76.99 | Low | 76.96 | High | 77.00 | Mkt Cap | 1.63B |
| Vol | 1.40M | Avg Vol | 1.34M | EPS | -4.57 | P/E | N/A | Forward P/E | -18.89 |
| Beta | 2.65 | Short Ratio | 0.82 | Inst. Own | 96.65% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-09 | 50-d Avg | 55.18 | 200-d Avg | 33.25 | 1yr Est | 73.00 |
| Income Statement | |||
| Operating Expenses | 24.60M | ||
| Research and Development Expense | 22.34M | ||
| Selling, General and Administrative Expense | 2.27M | ||
| Operating Income | -24.60M | ||
| Income Tax Expense | 193.00K | ||
| Net Income | -23.33M | ||
| Net Income Common Stock | -23.33M | ||
| Net Income Common Stock (USD) | -23.33M | ||
| Consolidated Income | -23.33M | ||
| Earnings per Basic Share | -0.97 | ||
| Earnings per Basic Share (USD) | -0.97 | ||
| Earnings per Diluted Share | -0.97 | ||
| Earning Before Interest & Taxes (EBIT) | -23.14M | ||
| Earning Before Interest & Taxes (USD) | -23.14M | ||
| Weighted Average Shares | 23.79M | ||
| Weighted Average Shares Diluted | 23.79M | ||
| Balance Sheet | |||
| Cash and Equivalents | 49.63M | ||
| Cash and Equivalents (USD) | 49.63M | ||
| Investments | 148.83M | ||
| Investments Current | 148.83M | ||
| Current Assets | 203.10M | ||
| Property, Plant & Equipment Net | 90.00K | ||
| Total Assets | 205.74M | ||
| Current Liabilities | 20.29M | ||
| Total Liabilities | 21.95M | ||
| Accumulated Retained Earnings (Deficit) | -268.84M | ||
| Accumulated Other Comprehensive Income | -54.00K | ||
| Shareholders Equity | 183.79M | ||
| Shareholders Equity (USD) | 183.79M | ||
| Assets Non-Current | 2.64M | ||
| Liabilities Non-Current | 1.66M | ||
| Trade and Non-Trade Payables | 14.01M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 20.00K | ||
| Net Cash Flow from Financing | 161.95M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -8.59M | ||
| Issuance (Purchase) of Equity Shares | 172.53M | ||
| Net Cash Flow from Investing | -147.84M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -147.84M | ||
| Net Cash Flow from Operations | -22.70M | ||
| Share Based Compensation | 3.67M | ||